- Excerpt from CBS Sunday Morning report on regenerative medicine
- More on Tengion's Product Pipeline
- Find Information on Clinical Trials
- Stay Informed with Email Alerts
Video: Tengion Neo-Urinary Conduit™
Watch as the neo-urinary conduit development process is described for use in patients with bladder cancer.
Video: Tengion Neo-Bladder Augment™ Construction
Tengion is developing products that seek to transform the treatment of organ and tissue impairment, failure and loss.
Abridged version (under 2 minutes)
This is the reason we get to work early every morning - there's a death every thirty seconds from organ failure. As I write this letter, there are 108,011 Americans on the waiting list for donor organs, and if they are fortunate enough to find one, they will face a lifetime of treatment to suppress their immune systems to prevent rejection. Read More »
Tengion Provides Corporate and Product Development Update and Reports Second Quarter 2010 Financial Results
August 11, 2010
Tengion Announces Second Quarter 2010 Results
August 4, 2010
Tengion Appoints A. Brian Davis Chief Financial Officer
August 2, 2010
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
July 7, 2010